Skip to main content
. 2012 Sep 12;2012(9):CD001901. doi: 10.1002/14651858.CD001901.pub2

Peltola 2009.

Methods Randomised, double‐blind, placebo‐controlled trial
2 treatment arms: 1 PCB and 1 LEV XR
Randomisation concealment: interactive voice response system. Random list generation: randomised 1:1 using interactive voice response system
Blinding: identical tablets and packages, all study personnel and participants were described as being blinded to treatment assignment
Baseline: 8 weeks. Treatment period = 12 weeks (no up‐titration took place)
Participants All adults. Multicentre (7 centres) including centres in Finland, India, Mexico, Russia, South Africa, and Ukraine 
 Total randomised: 158 adults 
 79 adults to PCB
79 adults to LEV XR 1000 mg 
 59% male in PCB and 66% male in LEV XR 
 Age range 12 to 70 years 
 Other AEDs 1 to 3 
 ≥ 8 focal seizures during 8‐week baseline within which ≥ 2 focal seizures per 4 weeks
Diagnosis of uncontrolled focal epilepsy made ≥ 6 months before screening
Mean duration of epilepsy (± SD) (years): LEV XR 13.11 ± 10.87 (range 0.8 to 42.6), PCB 16.43 ± 11.93 (range 0.7 to 53.5)
Mean baseline seizure frequency per week (mean ± SD): LEV XR 40.7 ± 66.0; PCB 30.6 ± 52.5
Interventions LEV XR 1000 mg
PCB
Outcomes ≥ 50% reduction in seizure frequency
Treatment withdrawal
Adverse effects
Notes 5 participants excluded from 50% responder analysis: 4 in LEV XR 1000 mg, 1 in PCB
2 patients randomised to LEV XR did not receive any medication; therefore, they were excluded from the safety population, leaving 77 patients on LEV XR and 79 on PCB in the safety analysis data‐set
Baseline level for determining reduction in seizure frequency was derived from 74 patients in LEV XR group and 78 in PCB
A few participants had other seizure types in addition to partial‐onset seizures
"Study personnel" taken to mean investigators
Risk of bias
Bias Authors' judgement Support for judgement
Random sequence generation (selection bias) Low risk A ‐ Adequate
Allocation concealment (selection bias) Low risk A ‐ Adequate
Blinding of participants and personnel (performance bias) 
 All outcomes Low risk A ‐ Adequate
Blinding of outcome assessment (detection bias) 
 All outcomes Low risk A ‐ Adequate
Incomplete outcome data (attrition bias) 
 All outcomes Low risk A ‐ Adequate
Selective reporting (reporting bias) Low risk A ‐ Adequate